The ADAPTation to Therapeutic Resistance Training (ADAPT) Study
- Conditions
- Muscle WeaknessMusculoskeletal Injury
- Registration Number
- NCT05719922
- Lead Sponsor
- Defence Medical Rehabilitation Centre, UK
- Brief Summary
In 2018, the Academic Department of Military Rehabilitation (ADMR) published a pilot randomised controlled trial (RCT), demonstrating the feasibility and acceptability of integrating twice-daily blood flow restriction (BFR) training into a busy residential care setting. Following its publication was a guidance note written by the Directorate of Defence Rehabilitation restricting the implementation of BFR training until more evidence can be provided to support its efficacy. This research trial is a fully-powered, multi-centre RCT investigating the efficacy and biological mechanism underpinning BFR therapy in UK military personnel with lower-limb musculoskeletal injury (specifically, persistent anterior knee pain) during residential rehabilitation. This study will aim to optimise both the rehabilitation outcome and improve the time-and cost-effectiveness of the service delivered across UK Defence Rehabilitation and beyond. Results will provide insight and knowledge to the clinical and scientific community to not only those embedded within Defence Rehabilitation, but also those working in civilian sector organisations and professional sport in the UK and abroad.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
- mechanical knee pain for at least three months
- present with clinical signs and symptoms of knee pain arising from the tibiofemoral or patellofemoral joint diagnosed by sport and exercise medicine physician and/or physiotherapist
- have reduced occupational employability medical grade secondary to their knee pain
- report progression of resistance training load within the patient's rehabilitation programme is limited by knee pain
- aged between 18 and 55 years
- available to attend for the entire duration of the RRU course and a review appointment 3-months following course.
diagnosed tibial, femoral or patella fracture and/or dislocation;
- present with instability in the knee resulting from ligament deficiency
- present with clinical signs and symptoms of patellar tendinopathy
- have planned surgery over the study period
- restricted knee range of movement; clinical signs and symptoms of non-musculoskeletal or serious pathological condition (i.e. Inflammatory arthropathy, infection or tumour) or referred pain from non-local pain source
- present with any physical impairment or co-morbidities (including cardio-vascular disease) precluding the safe participation in the rehabilitation programme and/or assessment procedures
- Cortico-steroid or analgesic injection intervention within the previous 7-days or previous knee surgery within the last 12 months to the affected limb
Medical Exclusion Criteria:
- History of cardiovascular disease including hypertension, peripheral vascular disease, thrombosis/embolism, ischaemic heart disease, myocardial infarction.
- History of the following musculoskeletal disorders: rheumatoid arthritis, avascular necrosis or osteonecrosis, severe osteoarthritis.
- History of the following neurological disorders: Peripheral neuropathy, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, severe traumatic brain injury.
- Varicose veins in the lower limb
- Acute viral or bacterial upper or lower respiratory infection at screening
- Known or suspected lower limb chronic exertional compartment syndrome (CECS)
- Postsurgical swelling
- Surgical insertion of metal components at the position of cuff inflation
- History of any of the following conditions or disorders not previously listed: diabetes, active cancer
- History of elevated risk of unexplained fainting or dizzy spells during physical activity/exercise that causes loss of balance
- History of haemorrhagic stroke or exercise induced rhabdomyolysis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in Lower Extremity Functional Scale (LEFS) over time Baseline, week 3 and week 15 LEFS is a 20-question patient-reported outcome measure (PROM) that measures functional status in patients with lower limb musculoskeletal injury. Questions on activity vary in physical demand from walking to running on uneven ground. The LEFS is a validated tool and has demonstrated good test-retest reliability and responsiveness in individuals with persistent knee pain.
- Secondary Outcome Measures
Name Time Method Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) over time Baseline, week 3 and week 15 Change in Sport Injury Rehabilitation Beliefs Survey (SIRBS) over time Baseline, week 3 and week 15 Change in Musculoskeletal Health Questionnaire (MSK-HQ) over time Baseline, week 3 and week 15 Change in Numeric Pain Rating Scale (NPRS) over time Baseline, week 3 and week 15 Change in decline knee bend over time Baseline, week 3 and week 15 Change in muscle volume and anatomical cross sectional area (CSA) using magnetic resonance imaging (MRI) over time Baseline, week 3 and week 15 Change in fascicle length over time using ultrasonography Baseline, week 3 and week 15 fascicle length measured in mm
Change in markers of endothelial function over time Baseline, week 3 and week 15 Using fasted blood samples. E.g., Vascular endothelial growth factor (µg/L)
Change in Patient Specific Functional Scale over time Baseline, week 3 and week 15 Health Anxiety Depression Scale (HADS) Baseline Change in functional Activity Assessment (FAA) over time Baseline and week 15 Change in Tampa Scale of Kinesiophobia (TSK) over time Baseline, week 3 and week 15 Change in International Physical Activity Questionnaire (IPAQ) over time Baseline, week 3 and week 15 Change in qualitative assessment of single leg squat (QASLS) over time Baseline, week 3 and week 15 Change in counter-movement jump over time Baseline, week 3 and week 15 Change in knee extension and flexion - maximal isometric voluntary contraction over time Baseline, week 3 and week 15 Change in bilateral squat over time - kinetic and kinematic analysis Baseline, week 3 and week 15 3D motion capture and force plate data will be used to collect kinetic and kinematic data which will be later analysed using inverse dynamics. Force measured in Newtons, Moments measured in Newton/Metres/kg
Change in daily monitoring of wellness score over time Daily for the 3 weeks of rehabilitation Subjective patient reported outcome measure of 'wellness' scored using a 5-point likert scale.
Change in isometric muscle strength of hip and knee using hand-held dynamometer over time Baseline, week 3 and week 15 Change in single leg squat over time - kinetic and kinematic analysis Baseline, week 3 and week 15 3D motion capture and force plate data will be used to collect kinetic and kinematic data which will be later analysed using inverse dynamics. Force measured in Newtons, Moments measured in Newton/Metres/kg
Change in markers of muscle damage over time Baseline, week 3 and week 15 Using fasted blood samples. E.g., Creatine Kinase (units/L)
Change in markers of inflammation over time Baseline, week 3 and week 15 Using fasted blood samples. E.g., Interleukin-6 (pg/ml)
Change in five Repetition Maximum Leg Press over time Baseline, week 3 and week 15 Change in single leg heel raises to fatigue over time Baseline, week 3 and week 15 Change in daily monitoring of session rate of perceived exertion (sRPE) over time Daily for the 3 weeks of rehabilitation Subjective patient reported outcome measure of exertion, scored 0 to 10 (0 = no exertion, 10= maximal exertion)
Change in daily monitoring of pain over time Daily for the 3 weeks of rehabilitation Subjective patient reported outcome measure of pain measured using a 0 to 100mm visual analog scale (VAS). 0= no pain, 100 = worst pain
Change in isometric midthigh pull over time Baseline, week 3 and week 15 Change in pennation angle over time using ultrasonography Baseline, week 3 and week 15 Pennation angle measured in degrees
Change in markers of oxidative stress over time Baseline, week 3 and week 15 Using fasted blood samples. E.g., Protein carbonyl (units/L)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (6)
RRU Aldershot
🇬🇧Aldershot, United Kingdom
RRU Colchester
🇬🇧Colchester, United Kingdom
RRU Cranwell
🇬🇧Cranwell, United Kingdom
RRU Edinburgh
🇬🇧Edinburgh, United Kingdom
RRU St Athan
🇬🇧St Athan, United Kingdom
RRU Bulford
🇬🇧Tidworth, United Kingdom
RRU Aldershot🇬🇧Aldershot, United KingdomOllie RosenstockContact